WallStreetZenWallStreetZen

NASDAQ: RVPH
Reviva Pharmaceuticals Holdings Inc Stock Ownership - Who owns Reviva Pharmaceuticals Holdings?

Insider buying vs selling

Have Reviva Pharmaceuticals Holdings Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when RVPH insiders and whales buy or sell their stock.

RVPH Shareholders

What type of owners hold Reviva Pharmaceuticals Holdings Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Laxminarayan Bhat8.90%2,484,244$4.25MInsider
Tenzing LLC7.60%2,121,750$3.63MInsider
Rahul Nayar6.89%1,924,250$3.29MInsider
Parag Saxena6.89%1,924,250$3.29MInsider
Woodline Partners LP3.78%1,055,009$1.80MInstitution
Glazer Capital LLC3.64%1,017,000$1.74MInsider
Vanguard Group Inc3.59%1,001,836$1.71MInstitution
Millennium Management LLC3.06%854,597$1.46MInstitution
Schonfeld Strategic Advisors LLC2.96%826,600$1.41MInstitution
Mizuho Securities Usa LLC 12.93%817,750$1.40MInsider

1 of 3

RVPH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RVPH19.44%38.25%
CTCX11.04%54.68%Net Buying
AADI27.59%72.41%Net SellingNet Selling
DYAI8.00%92.00%
GANX10.34%1.89%Net BuyingNet Buying

Reviva Pharmaceuticals Holdings Stock Ownership FAQ

Who owns Reviva Pharmaceuticals Holdings?

Reviva Pharmaceuticals Holdings (NASDAQ: RVPH) is owned by 19.44% institutional shareholders, 38.25% Reviva Pharmaceuticals Holdings insiders, and 42.31% retail investors. Laxminarayan Bhat is the largest individual Reviva Pharmaceuticals Holdings shareholder, owning 2.48M shares representing 8.90% of the company. Laxminarayan Bhat's Reviva Pharmaceuticals Holdings shares are currently valued at $4.25M.

If you're new to stock investing, here's how to buy Reviva Pharmaceuticals Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.